Medicines For Malaria Venture Supports Research With ‘Malaria Box’

Deutsche Welle examines Medicines for Malaria Venture’s (MMV) “Malaria Box,” which “holds 400 diverse compounds that kill the malaria parasite” and is distributed “free of charge to any researcher who wants it.” According to the news agency, “MMV aims to incite them to develop new, market-ready drugs based on one of the 400 compounds in the box.” DW adds, “Up to now, MMV has sent malaria boxes to 160 research groups in 27 countries, mainly to Europe and North America, but also to South Africa, India, Brazil and Uganda, for instance” (Osterath, 11/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.